Phase 1 Papillomavirus Infection Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Advanced Solid TumorsCarcinomaNeoplasms+9 more
Marengo Therapeutics, Inc.365 enrolled32 locationsNCT05592626
Not Yet Recruiting
Phase 1
Efficacy of iodine solution administered via a treatment applicator for treating human papillomavirus (HPV) infection of the cervix.
Cervical human papillomavirus infection
Jenny McClloskey60 enrolled1 locationACTRN12617000726358